NORTHWEST BIOTHERAPEUTICS INC: capital expenditure payments

Name: NORTHWEST BIOTHERAPEUTICS INC: capital expenditure payments
Creator: NORTHWEST BIOTHERAPEUTICS INC

Capital expenditure payments for NORTHWEST BIOTHERAPEUTICS INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All NORTHWEST BIOTHERAPEUTICS INC financial histories

What this measure means

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Capital expenditure payments in original reported units, latest-filed observation per period
Period start	Period end	Value	Unit	Filed	Source filing
2025-01-01	2025-12-31	1,504,000	USD	2026-04-15	10-K · 0001104659-26-043806
2024-01-01	2024-12-31	1,014,000	USD	2026-04-15	10-K · 0001104659-26-043806
2019-01-01	2019-12-31	171,000	USD	2020-03-16	10-K · 0001104659-20-034145
2013-01-01	2013-12-31	-1,000	USD	2014-04-01	10-K · 0001144204-14-020023
2012-01-01	2012-12-31	31,000	USD	2014-04-01	10-K · 0001144204-14-020023
2011-01-01	2011-12-31	49,000	USD	2013-04-08	10-K · 0001144204-13-020507
2010-01-01	2010-12-31	41,000	USD	2012-04-13	10-K · 0001144204-12-021574

Related financial histories

Inspect the source

Entity: NORTHWEST BIOTHERAPEUTICS INC / CIK 0001072379
Captured: 2026-09-20T05:19:52.407Z
SEC response SHA-256: 96ae5155e1f371497ff4e69acb04404a27b3c3c6ef981ce6f22dae4793393c44

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001072379.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))